| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Pathology, Health Sciences Center, State University of New York at Stony Brook, Stony Brook, New York 11794
A Mr 92,000 metalloprotease, originally observed in neutrophils, has been found to be secreted by various normal and malignant cells of fibroblastic, hematopoietic, and epithelial origin. The reponsiveness of the various cell types to the tumor promoter phorbol ester (phorbol myristate acetate) to secrete this enzyme and a corresponding Mr 72,000 gelatinase has been determined using gelatin zymograms. The latent zymogen form of the Mr 92,000 enzyme has been purified from phorbol myristate acetate-stimulated HT1080 human fibrosarcoma cells using sequential gelatin-Sepharose affinity chromatography and gel filtration. Selective elution from gelatin-Sepharose allows for a distinct separation of the Mr 92,000 gelatinase from the Mr 72,000 gelatinase. A fraction of the tumor cell derived latent Mr 92,000 enzyme is isolated as an apparent complex with human tissue inhibitor of metalloproteases, which is partially dissociated in sodium dodecyl sulfate and completely dissociated upon reduction of disulfide bonds and upon p-aminophenylmercuric acetate treatment. Organomercurial treatment rapidly allows for autoactivation of the proenzyme to active Mr 83,000 and Mr 75,000 species. At physiological pH, the enzyme rapidly degrades gelatin into small fragments and slowly cleaves native type V collagen at an apparent single site. Native type IV collagen is degraded to a much lesser extent. The NH2-terminal amino acid sequence of the Mr 92,000 proenzyme has been determined and is distinct from the Mr 72,000 gelatinase/type IV collagenase which is constitutively produced by fibroblasts. The Mr 92,000 enzyme is also immunologically distinct from the Mr 72,000 enzyme but immunologically cross-reactive with the neutrophil, high molecular weight gelatinase. The Mr 92,000 enzyme constitutes a distinct member of the matrix metalloprotease family. Its substrate specificity implies a broad physiological role, acting on basement membrane type V collagen as well as on denatured (gelatinized) collagens and thus may be involved in the invasive and migratory phenotype of human cells.
1 This work was supported in part by Grants CD 217N from the American Cancer Society and CA 16740 from the National Cancer Institute.
2 To whom requests for reprints should be addressed.
Received 3/22/90. Accepted 7/ 5/90.
This article has been cited by other articles:
![]() |
V. C. Ardi, P. E. Van den Steen, G. Opdenakker, B. Schweighofer, E. I. Deryugina, and J. P. Quigley Neutrophil MMP-9 Proenzyme, Unencumbered by TIMP-1, Undergoes Efficient Activation in Vivo and Catalytically Induces Angiogenesis via a Basic Fibroblast Growth Factor (FGF-2)/FGFR-2 Pathway J. Biol. Chem., September 18, 2009; 284(38): 25854 - 25866. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ries, V. Egea, M. Karow, H. Kolb, M. Jochum, and P. Neth MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines Blood, May 1, 2007; 109(9): 4055 - 4063. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Behzadian, X.-L. Wang, L. J. Windsor, N. Ghaly, and R. B. Caldwell TGF-{beta} Increases Retinal Endothelial Cell Permeability by Increasing MMP-9: Possible Role of Glial Cells in Endothelial Barrier Function Invest. Ophthalmol. Vis. Sci., March 1, 2001; 42(3): 853 - 859. [Abstract] [Full Text] |
||||
![]() |
H. Li, H. Simon, T. M.A. Bocan, and J.T. Peterson MMP/TIMP expression in spontaneously hypertensive heart failure rats: the effect of ACE- and MMP-inhibition Cardiovasc Res, May 1, 2000; 46(2): 298 - 306. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.T. Peterson, H. Li, L. Dillon, and J. W. Bryant Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat Cardiovasc Res, May 1, 2000; 46(2): 307 - 315. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Olson, M. M. Bernardo, M. Pietila, D. C. Gervasi, M. Toth, L. P. Kotra, I. Massova, S. Mobashery, and R. Fridman Characterization of the Monomeric and Dimeric Forms of Latent and Active Matrix Metalloproteinase-9. DIFFERENTIAL RATES FOR ACTIVATION BY STROMELYSIN 1 J. Biol. Chem., January 28, 2000; 275(4): 2661 - 2668. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-R. Roh, W.-J. Oh, B.-K. Yoon, and J.-H. Lee Up-regulation of matrix metalloproteinase-9 in human myometrium during labour: a cytokine-mediated process in uterine smooth muscle cells Mol. Hum. Reprod., January 1, 2000; 6(1): 96 - 102. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ramos-DeSimone, E. Hahn-Dantona, J. Sipley, H. Nagase, D. L. French, and J. P. Quigley Activation of Matrix Metalloproteinase-9 (MMP-9) via a Converging Plasmin/Stromelysin-1 Cascade Enhances Tumor Cell Invasion J. Biol. Chem., May 7, 1999; 274(19): 13066 - 13076. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Iizasa, T. Fujisawa, M. Suzuki, S.-i. Motohashi, K. Yasufuku, T. Yasukawa, M. Baba, and M. Shiba Elevated Levels of Circulating Plasma Matrix Metalloproteinase 9 in Non-Small Cell Lung Cancer Patients Clin. Cancer Res., January 1, 1999; 5(1): 149 - 153. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Olson, M. Toth, D. C. Gervasi, Y. Sado, Y. Ninomiya, and R. Fridman High Affinity Binding of Latent Matrix Metalloproteinase-9 to the alpha 2(IV) Chain of Collagen IV J. Biol. Chem., April 24, 1998; 273(17): 10672 - 10681. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.R. Lijnen, J. Silence, B. Van Hoef, and D. Collen Stromelysin-1 (MMP-3)-Independent Gelatinase Expression and Activation in Mice Blood, March 15, 1998; 91(6): 2045 - 2053. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Backstrom, G. P. Lim, M. J. Cullen, and Z. A. Tokes Matrix Metalloproteinase-9 (MMP-9) Is Synthesized in Neurons of the Human Hippocampus and Is Capable of Degrading the Amyloid-beta Peptide (1-40) J. Neurosci., December 15, 1996; 16(24): 7910 - 7919. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Yao, J.-M. Buhler, M. P. d'Ortho, F. Lebargy, C. Delclaux, A. Harf, and C. Lafuma Expression of Matrix Metalloproteinase Gelatinases A and B by Cultured Epithelial Cells from Human Bronchial Explants J. Biol. Chem., June 28, 1996; 271(26): 15580 - 15589. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kylmaniemi, A. Oikarinen, K. Oikarinen, and T. Salo Effects of Dexamethasone and Cell Proliferation on the Expression of Matrix Metalloproteinases in Human Mucosal Normal and Malignant Cells Journal of Dental Research, March 1, 1996; 75(3): 919 - 926. [Abstract] [PDF] |
||||
![]() |
Y. Ogata, Y. Itoh, and H. Nagase Steps Involved in Activation of the Pro-matrix Metalloproteinase 9 (Progelatinase B)-Tissue Inhibitor of Metalloproteinases-1 Complex by 4-Aminophenylmercuric Acetate and Proteinases J. Biol. Chem., August 4, 1995; 270(31): 18506 - 18511. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Harvey, K. Leco, M. Arcellana-Panlilio, X Zhang, D. Edwards, and G. Schultz Proteinase expression in early mouse embryos is regulated by leukaemia inhibitory factor and epidermal growth factor Development, January 4, 1995; 121(4): 1005 - 1014. [Abstract] [PDF] |
||||
![]() |
B. Himelstein, R Canete-Soler, E. Bernhard, and R. Muschel Induction of fibroblast 92 kDa gelatinase/type IV collagenase expression by direct contact with metastatic tumor cells J. Cell Sci., January 2, 1994; 107(2): 477 - 486. [Abstract] [PDF] |
||||
![]() |
H. Birkedal-Hansen, W.G.I. Moore, M.K. Bodden, L.J. Windsor, B. Birkedal-Hansen, A. DeCarlo, and J.A. Engler Matrix Metalloproteinases: A Review Critical Reviews in Oral Biology & Medicine, January 1, 1993; 4(2): 197 - 250. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Hahn-Dantona, R. T. Aimes, and J. P. Quigley The Isolation, Characterization, and Molecular Cloning of a 75-kDa Gelatinase B-like Enzyme, a Member of the Matrix Metalloproteinase (MMP) Family. AN AVIAN ENZYME THAT IS MMP-9-LIKE IN ITS CELL EXPRESSION PATTERN BUT DIVERGES FROM MAMMALIAN GELATINASE B IN SEQUENCE AND BIOCHEMICAL PROPERTIES J. Biol. Chem., December 22, 2000; 275(52): 40827 - 40838. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |